Biotech and Money New York 2015 – 17 November 2015

Venue: TKP New York Conference Center

Location (city and country): New York, US

Event Website

Biotech and Money New York provides the education, strategies and solutions executives need to enable more effective funding, investment, business planning, partnering and strategic decision making within their business.

It’s where life science meets money, investors meet deal flow and industry promote strategic collaborations.

Detailed summary:

Biotech and Money New York aims to provide genuine peer 2 peer knowledge sharing, networking and deal making opportunities between CxO level executives, and uncover new ideas to move the industry forward. At its heart is a mission to promote NYC and the region as a center for life science excellence and help build linkages and business opportunities between East Coast life science companies and capital.

The congress is a catalyst for dialogue, debate and deal making to help lead growth in life science and healthcare investment and the building of billion dollar businesses. The congress will help forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in in the industry.

The congress will help promote NYC as a center for life sciences, and provide a physical platform and forum for advancing translation and connecting innovative life science companies with capital and partnership opportunities.

HOW IT’S DIFFERENT

  • A qualified executive-level audience
  • Innovative formats; no powerpoint
  • Content to match your investment / partnering lifecycle
  • Online showcases and company profiling
  • Qualified 1-2-1 partnering
  • No CROs, CMOs or EQMs present

WHO IS SPEAKING

Keynote speakers include:

  • Marc Tessier-Lavigne, President, Rockefeller University
  • Michael Foley, Sanders Director, Tri-Institutional Therapeutics Discovery Institute & The Sanders Innovation and Education Initiative
  • Louis Walcer, ‪Director, Kevin M. McGovern Family Center for Venture Development in the Life Sciences, Cornell University
  • Tom Maniatis, Chairman of the Department of Biochemistry and Molecular Biophysics, and Director of Precision Medicine, Columbia University, and Cofounder, New York Genome Center
  • Susan Solomon, CEO, The NY Stem Cell Foundation
  • Todd Sherer, ‪CEO, The Michael J. Fox Foundation for Parkinson’s Research
  • Judy Dunn, VP, Global Head, Clinical Development, Roche

5 REASONS TO ATTEND

  1. Access capital. Find investors and suitable funding and financing sources
  2. Engage partners. Identify partners of choice and conduct deal making
  3. Generate new ideas. Learn from your peers and generations of successful executives
  4. Find new sources of innovation. Meet the innovators, inventors and entrepreneurs with commercial potential
  5. Network, partner and carry out business development with decision makers and c-level executives

 

 

/0 Comments/by

FreeMind is Proud to Support the RESI Conference on September 16th – Boston

Life Science Nation (LSN) and Johnson & Johnson Innovation, JLABS (JLABS) are inviting fundraising life science companies to attend the upcoming Redefining Early Stage Investments (RESI) Conference in Boston on September 16th.

 

The first RESI Conference took place on September 16, 2013, and two years later, following highly successful events in San Francisco and Houston, LSN returns to Boston for the sixth RESI Conference. With new and returning sponsors including Johnson & Johnson Innovation JLABS, Charles River Laboratories, McDermott Will & Emory, and Wuxi AppTec, this event is expected to be the largest RESI so far, with more content and more meetings than ever. Also, JLABS will be hosting a cocktail reception to wrap up the event.

 

About RESI

The RESI Conference brings together the most diverse group of early stage investors under one roof, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more. The RESI Partnering Forum allows fundraising executives to identify and book up to 16 meetings with life science investors who fit their company’s technology sector and stage of development. This one day conference provides the highest ROI in the industry by bringing together innovative technology and active early stage investors looking to deploy capital.

/0 Comments/by

Come meet FreeMind at our booth at BIO – Booth 4259

Come say hello at our booth at the Bio International Convention taking place in Philadelphia – June 15 – 18, 2015.

Ram May-Ron, Managing Partner, FreeMind Group and Guy-Har-Chen, FreeMind’s Chief Analyst will be taking meetings throughout the day in the booth. Come by for an Espresso, or drop your card to win a giant whiskey! (3.5L Grants)

Ayal Ronen, Vice President, FreeMind Group and Jonathan Adalist from the Business Development team are also attending the event and primarily meeting with future clients in the Business Forum.

FreeMind Booth – 4259

 

/0 Comments/by